Single passive leg movement assessment of vascular function: contribution of nitric oxide.

The assessment of passive leg movement (PLM)-induced leg blood flow (LBF) and vascular conductance (LVC) is a novel approach to assess vascular function that has recently been simplified to only a single PLM (sPLM), thereby increasing the clinical utility of this technique. As the physiological mechanisms mediating the robust increase in LBF and LVC with sPLM are unknown, we tested the hypothesis that nitric oxide (NO) is a major contributor to the sPLM-induced LBF and LVC response. In nine healthy men, sPLM was performed with and without NO synthase inhibition by intra-arterial infusion of NG-monomethyl-L-arginine (L-NMMA). Doppler ultrasound and femoral arterial pressure were used to determine LBF and LVC, which were characterized by the peak change (Delta wLBF(peak) and Delta LVCpeak) and area under the curve (LBFAUC and LVCAUC). L-NMMA significantly attenuated Delta LBFpeak [492 +/- 153 (L-NMMA) vs. 719 +/- 238 (control) ml/min], LBFAUC [57 +/- 34 (L-NMMA) vs. 147 +/- 63 (control) ml], Delta LVCpeak [4.7 +/- 1.1 (L-NMMA) vs. 8.0 +/- 3.0 (control) ml . min(-1) . mmHg(-1)], and LVCAUC [0.5 +/- 0.3 (L-NMMA) vs. 1.6 +/- 0.9 (control) ml/mmHg]. The magnitude of the NO contribution to LBF and LVC was significantly correlated with the magnitude of the control responses (r = 0.94 for Delta LBFpeak, r = 0.85 for LBFAUC, r = 0.94 for Delta LVCpeak, and r = 0.95 for LVCAUC). These data establish that the sPLM-induced hyperemic and vasodilatory response is predominantly (similar to 65%) NO-mediated. As such, sPLM appears to be a promising, simple, in vivo assessment of NO-mediated vascular function and NO bioavailability. NEW & NOTEWORTHY Passive leg movement (PLM), a novel assessment of vascular function, has been simplified to a single PLM (sPLM), thereby increasing the clinical utility of this technique. However, the role of nitric oxide (NO) in mediating the robust sPLM hemodynamic responses is unknown. This study revealed that sPLM induces a hyperemic and vasodilatory response that is predominantly NO-mediated and, as such, appears to be a promising simple, in vivo, clinical assessment of NO-mediated vascular function and, therefore, NO bioavailability.